Turn Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TTRX | RLMD | PTHS | HRTX | BETR.CN | PTX.AX | |
|---|---|---|---|---|---|---|
| Market cap | 297.60M | 444.81M | 39.91M | 56.69M | 142.14M | 60.62M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -65.3 | -10.2 | -1.9 | -2.7 | — | 5.3 |
| Price/book | 426.1 | 2.2 | -25.1 | 9.6 | -3.5 | 3.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +130.59% | +59.77% | −72.88% | −74.77% | +283.33% | +10.87% |
| Today | +3.05% | −2.34% | −5.84% | +4.88% | +2.22% | +3.92% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All TTRX news ›Turn Therapeutics Inc. (TTRX) - What Are Brokerages Thinking About This Stock?
Check Out Our Latest Analysis on Turn Therapeutics Turn Therapeutics (NASDAQ:TTRX - Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported ($0.20) earnings per share for the quarter. As a group,…
Turn Therapeutics (NASDAQ:TTRX) Raised to Hold at Wall Street Zen
Posted by Defense World Staff on Oct 31st, 2026 Turn Therapeutics (NASDAQ:TTRX – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com2
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.